Occup Environ Med

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

The most recent version of this article was published on 1 June 2008

Occup Environ Med. Published Online First: 21 November 2007. doi:10.1136/oem.2007.034256
Copyright © 2007 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
oem.2007.034256v1
65/6/420    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luben, T. J
Right arrow Articles by Reif, J. S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luben, T. J
Right arrow Articles by Reif, J. S

Original Article

Maternal Exposure to Water Disinfection By-Products during Gestation and Risk of Hypospadias

Thomas J Luben 1*, John R Nuckols 2, Bridget S Mosley 3, Charlotte Hobbs 3 and John S Reif 2

1 U.S. EPA, United States
2 Colorado State University, United States
3 University of Arkansas for Medical Sciences and Arkansas Children’s Hospital Research Institute, United States

* To whom correspondence should be addressed. E-mail: luben.tom{at}epa.gov.

Accepted 16 November 2007


*   Abstract

Background: The use of chlorine for water disinfection results in the formation of numerous contaminants called disinfection by-products (DBPs), which may be associated with birth defects, including urinary tract defects. Methods: We used Arkansas birth records (1998-2002) to conduct a population-based case-control study investigating the relationship between hypospadias and two classes of DBPs, trihalomethanes (THMs) and haloacetic acids (HAAs). We utilized monitoring data, spline regression and GIS to link daily concentrations of these from 263 water utilities to 320 cases and 614 controls. We calculated ORs for hypospadias and exposure to DBPs between 6 and 16 weeks gestation, and conducted subset analyses for exposure from ingestion, and metrics incorporating consumption, showering and bathing. Results: We found no increase in risk when women in the highest tertiles of exposure were compared to those in the lowest for any DBP. When ingestion alone was used to assess exposure among a subset of 40 cases and 243 controls, the intermediate tertiles of exposure to total THMs and the five most common HAAs had ORs of 2.11 (95% CI = 0.89-5.00) and 2.45 (95% CI = 1.06-5.67), respectively, compared to women with no exposure. When exposure to total THMs from consumption, showering and bathing exposures was evaluated, we found an OR of 1.96 (95% CI = 0.65-6.42) for the highest tertile of exposure and weak evidence of a dose-response relationship. Conclusions: Our results provide little evidence for a positive relationship between DBP exposure during gestation and an increased risk of hypospadias, but emphasize the necessity of including individual-level data when assessing exposure to DBPs.


Keywords: Birth Defect, Disinfection By-Product, Haloacetic Acid, Hypospadias, Trihalomethane







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd.